Chemotherapy-Induced Nausea and Vomiting (CINV) – Antiemetics

Therapy Initiation Resources

• Measures
  • Measure 114 – NK1 Receptor Antagonist (aprepitant, fosaprepitant, netupitant) or Olanzapine administered for low or moderate emetic risk Cycle 1 chemotherapy (Lower Score – Better)
  • Measure 115 – NK1 Receptor Antagonist and Olanzapine prescribed or administered with high emetic risk chemotherapy